Xenon Pharmaceuticals (FRA:XP0) Buildings And Improvements : €7.05 Mil (As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Xenon Pharmaceuticals Buildings And Improvements?

Xenon Pharmaceuticals's quarterly buildings and improvements increased from Sep. 2024 (€7.44 Mil) to Dec. 2024 (€7.58 Mil) but then declined from Dec. 2024 (€7.58 Mil) to Mar. 2025 (€7.05 Mil).

Xenon Pharmaceuticals's annual buildings and improvements declined from Dec. 2022 (€9.82 Mil) to Dec. 2023 (€8.43 Mil) and declined from Dec. 2023 (€8.43 Mil) to Dec. 2024 (€7.58 Mil).

Xenon Pharmaceuticals Buildings And Improvements Historical Data

The historical data trend for Xenon Pharmaceuticals's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xenon Pharmaceuticals Buildings And Improvements Chart

Xenon Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Buildings And Improvements

Get a 7-Day Free Trial

2.73

7.13

9.82

8.43

7.58

Xenon Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Buildings And Improvements	Get a 7-Day Free Trial															8.17	7.96	7.44	7.58	7.05

Xenon Pharmaceuticals Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Xenon Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xenon Pharmaceuticals Inc (FRA:XP0) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

XENE:USA

Address

200-3650 Gilmore Way, Burnaby, BC, CAN, V5G 4W8

Website

https://www.xenon-pharma.com

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Xenon Pharmaceuticals Headlines

No Headlines